Gull Global Ltd

All filings by Gull Global Ltd on record concern Usana Health Sciences Inc. Over a trading history stretching from 8 April 2015 to 4 February 2019, the count stands at 166 filings.

In open-market terms, that means 4 purchases worth €1.1M on one side and 159 sales worth €227.5M on the other. Taken together, the sales exceed the purchases by €226.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2019 to date brings no purchases and 19 sales.

Half of the purchases are above €236k and half below. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +14.4%. They describe history only and say nothing certain about the share price ahead.

On 5 February 2019 came the latest disclosure, an open-market sale for €865k in Usana Health Sciences Inc. The most recent open-market purchase was published on 31 May 2018, 3,083 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.